Anti-carcinoembryonic antigen immunity.
DeBenedette
Mark
M
Aventis Pasteur, Toronto, Ontario, Canada.
Radvanyi
Laszlo
L
Singh-Sandhu
Devender
D
Berinstein
Neil L
NL
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007167:Immunotherapy / Q000379:methods; D016219:Immunotherapy, Adoptive; D009369:Neoplasms / Q000276:immunology*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D002272:Carcinoembryonic Antigen